These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6389237)

  • 1. Favourable outcome of hepatic veno-occlusive disease in a renal transplant patient receiving azathioprine, treated by portacaval shunt. Report of a case and review of the literature.
    Eisenhauer T; Hartmann H; Rumpf KW; Helmchen U; Scheler F; Creutzfeldt W
    Digestion; 1984; 30(3):185-90. PubMed ID: 6389237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic vascular disease after kidney transplantation: report of two cases and review of the literature.
    Adler M; Delhaye M; Deprez C; Hardy N; Gelin M; De Pauw L; Vereerstraeten P; Cremer M; Toussaint C
    Nephrol Dial Transplant; 1987; 2(3):183-8. PubMed ID: 3114679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic veno-occlusive disease in a renal transplant patient receiving azathioprine.
    Marubbio AT; Danielson B
    Gastroenterology; 1975 Sep; 69(3):739-43. PubMed ID: 1098955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azathioprine and hepatic venocclusive disease in renal transplant patients.
    Katzka DA; Saul SH; Jorkasky D; Sigal H; Reynolds JC; Soloway RD
    Gastroenterology; 1986 Feb; 90(2):446-54. PubMed ID: 3510146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic veno-occlusive disease associated with renal transplantation and azathioprine therapy.
    Read AE; Wiesner RH; LaBrecque DR; Tifft JG; Mullen KD; Sheer RL; Petrelli M; Ricanati ES; McCullough AJ
    Ann Intern Med; 1986 May; 104(5):651-5. PubMed ID: 3008617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of hepatic venocclusive disease in a bone marrow transplant patient with side-to-side portacaval shunt.
    Murray JA; LaBrecque DR; Gingrich RD; Pringle KC; Mitros FA
    Gastroenterology; 1987 Apr; 92(4):1073-7. PubMed ID: 3549421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of severe azathioprine-induced hepatic veno-occlusive disease in a kidney-transplanted patient with transjugular intrahepatic portosystemic shunt.
    Azoulay D; Castaing D; Lemoine A; Samuel D; Majno P; Reynes M; Charpentier B; Bismuth H
    Clin Nephrol; 1998 Aug; 50(2):118-22. PubMed ID: 9725784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Veno-occlusive hepatic disease of the liver in renal transplantation: is azathioprine the cause?
    Liaño F; Moreno A; Matesanz R; Teruel JL; Redondo C; García-Martín F; Orte L; Ortuño J
    Nephron; 1989; 51(4):509-16. PubMed ID: 2662036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of endothelial cell injury in the spectrum of azathioprine-induced liver disease after renal transplant: light microscopy and ultrastructural observations.
    Haboubi NY; Ali HH; Whitwell HL; Ackrill P
    Am J Gastroenterol; 1988 Mar; 83(3):256-61. PubMed ID: 3278593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hepatic veno-occlusive disease associated to the use of azathioprine in a renal transplant recipient].
    Hola K; Brahm J; Alvo M; Cotera A; Passalacqua W; Smok G
    Rev Med Chil; 1996 Dec; 124(12):1489-91. PubMed ID: 9334484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Veno-occlusive disease of the liver and Budd-Chiari syndrome].
    Leger L; Dentan T; Parc R; Colin A; Desplace A; Lemaigre G
    Presse Med (1893); 1970 Aug; 78(36):1561-4. PubMed ID: 5466088
    [No Abstract]   [Full Text] [Related]  

  • 12. Veno-occlusive disease of the liver after marrow transplantation: histological correlates of clinical signs and symptoms.
    Shulman HM; Fisher LB; Schoch HG; Henne KW; McDonald GB
    Hepatology; 1994 May; 19(5):1171-81. PubMed ID: 8175139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Azathioprine-induced hepatic veno-occlusive disease in a renal transplant recipient: histological regression following azathioprine withdrawal.
    Kohli HS; Jain D; Sud K; Jha V; Gupta KL; Sakhuja V; Joshi K
    Nephrol Dial Transplant; 1996 Aug; 11(8):1671-2. PubMed ID: 8856241
    [No Abstract]   [Full Text] [Related]  

  • 14. Life-threatening veno-occlusive disease after living-related liver transplantation.
    Nakazawa Y; Chisuwa H; Mita A; Ikegami T; Hashikura Y; Terada M; Nakayama J; Kawasaki S
    Transplantation; 2003 Mar; 75(5):727-30. PubMed ID: 12640317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Four hundred and twenty-three consecutive adults piggy-back liver transplantations with the three suprahepatic veins: was the portal systemic shunt required?
    Audet M; Piardi T; Panaro F; Cag M; Habibeh H; Gheza F; Portolani N; Cinqualbre J; Jaeck D; Wolf P
    J Gastroenterol Hepatol; 2010 Mar; 25(3):591-6. PubMed ID: 19968745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 6-thioguanine as a cause of toxic veno-occlusive disease of the liver.
    Satti MB; Weinbren K; Gordon-Smith EC
    J Clin Pathol; 1982 Oct; 35(10):1086-91. PubMed ID: 6957419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Veno-occlusive disease of the liver after high-dose mitomycin C therapy and autologous bone marrow transplantation.
    Lazarus HM; Gottfried MR; Herzig RH; Phillips GL; Weiner RS; Sarna GP; Fay J; Wolff SN; Sudilovsky O; Gale RP; Herzig GP
    Cancer; 1982 May; 49(9):1789-95. PubMed ID: 7042075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical case of the month. Hepatoportal sclerosis in a patient treated with azathioprine].
    Roland S; Delwaide J; Cornet G; Mahieu P; Jacquet N; Belaiche J
    Rev Med Liege; 1998 Aug; 53(8):450-3. PubMed ID: 9810203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental, clinical, and metabolic results of side-to-side portacaval shunt for intractable cirrhotic ascites.
    Orloff MJ; Orloff MS; Orloff SL; Girard B
    J Am Coll Surg; 1997 Jun; 184(6):557-70. PubMed ID: 9179111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic sinusoidal dilatation with portal hypertension during azathioprine treatment after kidney transplantation.
    Gerlag PG; Lobatto S; Driessen WM; Deckers PF; Van Hooff JP; Schröder E; Assmann KM; Van Haelst UJ
    J Hepatol; 1985; 1(4):339-48. PubMed ID: 3902952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.